Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL3899056 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL11836237 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL6227892 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL11903623 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL1129433 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL7201448 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL3695831 | 0.96 | LMNA (0.48) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL11147445 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL5026914 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 | |
| Cadaverine Tartrate SCHEMBL3707555 | 0.96 | TSHR (0.44) | TSHRLMNACA4CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080382-A | Isosorbide type polycarbonate and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260142172-A1 | SECONDARY BATTERY AND POWER CONSUMING APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2026-05-21 | — | — | US | claimed |
| CN-122029657-A | Battery monomer and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4726802-A1 | SECONDARY BATTERY AND ELECTRIC DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2026-04-15 | — | — | EP | claimed |
| US-20260097044-A1 | ION PAIR LIQUID CRYSTAL FORMULATIONS FOR LONG-ACTING INJECTABLES OF POORLY SOLUBLE DRUGS | FORDOZ PHARMA CORP. (US) | 2026-04-09 | — | — | US | claimed |
| US-20260070797-A1 | PREPARATION METHOD AND USE OF FUNCTION TYPE ACTIVE ALUMINOSILICATE | FUZHOU UNIVERSITY (CN) | 2026-03-12 | — | — | US | claimed |
| EP-3825278-B1 | METHOD FOR PREPARING HIGH-PURITY BISFLUOROSULFONYLIMIDE SALT | SHANGHAI ROLECHEM CO LTD (CN) | 2025-12-17 | — | — | EP | claimed |
| CN-120149759-A | Battery cell, battery device and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120149508-A | Secondary battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120127297-A | Battery cell, battery device and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-0662727-B1 | Nonaqueous secondary battery, positive-electrode active material and process for making the same | SHARP KK (JP) | 1998-04-01 | — | — | EP | claimed |
| EP-0794155-A1 | Lithium nickel composite oxide, preparation process therefor and application thereof | SHARP KABUSHIKI KAISHA (JP) | 1997-09-10 | — | — | EP | claimed |
| US-5520850-A | BINDERS AND CONDUCTORS IN MULTILAYER ELEMENTS | CHALONER-GILL BENJAMIN (US) | 1996-05-28 | — | — | US | claimed |
| US-5478672-A | Nonaqueous secondary battery, positive-electrode active material | SHARP KABUSHIKI KAISHA (JP) | 1995-12-26 | — | — | US | claimed |
| EP-0662727-A1 | Nonaqueous secondary battery, positive-electrode active material and process for making the same | SHARP KABUSHIKI KAISHA (JP) | 1995-07-12 | — | — | EP | claimed |
| US-5399447-A | Batteries | VALENCE TECHNOLOGY, INC. (US) | 1995-03-21 | — | — | US | claimed |
| US-5338473-A | Aqueous mixture of blue cobaltous hydroxide and complex of cobaltous ion and alpha-hydroxy or alpha-amino carboxylic acid | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-08-16 | — | — | US | claimed |
| US-5057299-A | Decomposing complex of cobaltous compound with an hydroxide | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-10-15 | — | — | US | claimed |
| US-3994729-A | DIALDEHYDES, FIXING WITH THIOSULFATES, ALUMINUM SALT, TARTARIC ACID OR CITRIC ACID | FUJI PHOTO FILM CO., LTD. (JA) | 1976-11-30 | — | — | US | claimed |
| US-3956236-A | NYLON, POLYESTERS, OR POLYURETHANES | ALLIED CHEMICAL CORPORATION (US) | 1976-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260142172-A1 | SECONDARY BATTERY AND POWER CONSUMING APPARATUS | VMP1, INO80C, HVCN1 | TSHR 2958/4885LMNA 933/4885CA4 640/4885 |
| US-20260070797-A1 | PREPARATION METHOD AND USE OF FUNCTION TYPE ACTIVE ALUMINOSILICATE | CA2, SOD1, CA3 | TSHR 4325/4885LMNA 1887/4885CA4 45/4885 |
| US-20260097044-A1 | ION PAIR LIQUID CRYSTAL FORMULATIONS FOR LONG-ACTING INJECTABLES OF POORLY SOLUBLE DRUGS | SSB, LTB4R2, THRB | TSHR 14/4885LMNA 1173/4885CA4 2442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.